Keyword: Ireland

The additional tax charge is related to the $1.64 billion breakup fee AbbVie paid Shire in its nixed $55 billion takeover bid five years ago.

Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.

After years of negotiation and work stoppage threats, Pfizer is backing off on plans to overhaul pension plans at some of its Irish plants.

WuXi Biologics last year picked Ireland for its first manufacturing site outside of China. Now it says it will build a vaccine plant at the same site.

Roche has spent years reprioritizing its manufacturing spending, and as part of that process, it's exiting a small molecule site in Ireland.

South Korea's SK Holdings is rolling three API operations into a new unit, SK Pharmteco, and has put its headquarters in Sacramento, California.

U.K.-based CDMO PCI Pharma Services is expanding near Dublin as part of its “robust Brexit plan for continuity of pharmaceutical supply.”

GlaxoSmithKline will unload an API plant to Thermo Fisher Scientific for €90 million. The U.S. company says it is glad to get it.

Ireland-based Nabriva had one of its new antibiotics rejected by the FDA because of problems with a contract manufacturer in Europe.

Allergan is finishing a $156.2 million investment in a biologics manufacturing facility at its Westport, Ireland, site while adding 63 jobs.